TY  - JOUR
T1  - Amlodipine‑induced reversible gum hypertrophy
A1  - Gutch Manish
A1  - Shakya Shobhit
A1  - Kumar Sukriti
A1  - Annesh Bhattacharjee
A1  - Rao Somendra Singh
JF  - Archives of Pharmacy Practice
JO  - Arch Pharm Pract
SN  - 2320-5210
Y1  - 2016
VL  - 7
IS  - 3
SP  - 103
EP  - 105
N2  - Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45‑year‑old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.
UR  - https://archivepp.com/article/amlodipineinduced-reversible-gum-hypertrophy
ER  -